T1	binds-controller 471 503	deletion of the PH domain (ΔPH) 
T2	binds-strength 503 518	did not reduce 
T4	binds-controller 522 528	HGF/SF
T5	binds-constituent2 554 558	Shp2
T6	binds-constituent2 560 564	CRKL
T7	binds-constituent2 569 576	PI(3)K 
T10	binds-constituent1 589 593	CRKL
T11	binds-strength 606 615	abrogated
T13	binds-strength 693 709	strongly reduced
T14	binds-constituent2 713 762	the mutant lacking the CRKL-binding region (ΔCBR)
T15	binds-constituent1 770 775	Shp2 
T17	binds-site 799 824	the COOH terminus of Gab1
T20	binds-site 839 844	Y628 
T21	binds-constituent2 864 873	Gab1ΔShp2
T23	binds-constituent1 924 948	the Gab1 mutant ΔPI(3)K 
T24	binds-site 962 1015	mutations in all three PI(3)K consensus binding sites
T26	binds-site 1042 1067	the p85 subunit of PI(3)K
T27	binds-strength 1081 1094	less strongly
T28	binds-constituent1 1100 1114	wild-type Gab1
T30	binds-constituent1 1128 1134	PI(3)K
T33	binds-constituent2 1168 1202	Gab1Cter lacking amino acids 1–449
T35	binds-strength 1228 1244	strongly reduced
T36	binds-site 1248 1334	mutation of the remaining PI(3)K consensus binding sites, Y473 and Y590 (CterΔPI(3)K) 
T37	transfection-molecule 95 99	Gab1
T38	process 121 142	transiently expressed
T39	cell-type 146 155	293 cells
T40	incubation-reagent 196 202	HGF/SF
T41	assay-molecule 267 271	CRKL
T42	assay-molecule 273 276	p85
T43	assay-molecule 278 282	Shp2
T44	assay-molecule 288 292	Gab1
T45	binds-site 306 327	The PH domain of Gab1
T46	binds-constituent1 323 327	Gab1
T8	binds-site 652 677	the COOH terminus of Gab1
T12	binds-site 732 755	the CRKL-binding region
T3	binds-constituent2 619 688	the Gab1 mutants expressing only the COOH terminus of Gab1 (Gab1Cter)
T9	binds-constituent2 820 824	Gab1
T16	binds-constituent2 1061 1067	PI(3)K
T18	binds-constituent1 1321 1332	CterΔPI(3)K
T19	binds-constituent2 362 375	phospholipids
